A Message From the President of IDSOG-USA
The International Infectious Diseases Society for Obstetrics and Gynecology-USA (IIDSOG-USA) held its Third Annual Meeting in New Orleans, May 9 and 10, 1998 . During the meeting, there was a heated discussion about antepartum screening and treatment of infection to lower the incidence of preterm labor and delivery.
On May 14, 1998, based We recognize and acknowledge that the associations between these microbial abnormalities and prematurity need further study. We support controlled intervention trials without a placebo arm to determine the best therapeutic strategies for these women. However, should all women at risk for prematurity be denied potentially helpful therapeutic intervention while we wait for the results of these trials? We do not think so.
We support antepartum screening for the following abnormal microbial conditions in pregnancy. 
